Metabolic syndrome is a condition characterized by a clustering of metabolic abnormalities associated with an increased risk of type 2 diabetes and cardiovascular disease. An impaired insulin-stimulated myocardial glucose metabolism has been shown to be a risk factor for the development of cardiovascular disease in patients with type 2 diabetes. Whether cardiac insulin resistance occurs in subjects with metabolic syndrome remains uncertain. To investigate this issue, we evaluated myocardial glucose metabolic rate using cardiac dynamic F-18-FDG-PET combined with euglycemic-hyperinsulinemic clamp in three groups: a group of normal glucose tolerant individuals without metabolic syndrome (n = 10), a group of individuals with type 2 diabetes and metabolic syndrome (n = 19), and a group of subjects with type 2 diabetes without metabolic syndrome (n = 6). After adjusting for age and gender, individuals with type 2 diabetes and metabolic syndrome exhibited a significant reduction in insulin-stimulated myocardial glucose metabolic rate (10.5 +/- 9.04 mu mol/min/100 g) as compared with both control subjects (32.9 +/- 9.7 mu mol/min/100 g; P < 0.0001) and subjects with type 2 diabetes without metabolic syndrome (25.15 +/- 4.92 mu mol/min/100 g; P = 0.01). Conversely, as compared with control subjects (13.01 +/- 8.53 mg/min x Kg FFM), both diabetic individuals with metabolic syndrome (3.06 +/- 1.7 mg/min x Kg FFM, P = 0.008) and those without metabolic syndrome (2.91 +/- 1.54 mg/min x Kg FFM, P = 0.01) exhibited a significant reduction in whole-body insulin-stimulated glucose disposal, while no difference was observed between the 2 groups of subjects with type 2 diabetes with or without metabolic syndrome. Univariate correlations showed that myocardial glucose metabolism was positively correlated with insulin-stimulated glucose disposal (r = 0.488, P = 0.003), and negatively correlated with the presence of metabolic syndrome (r = -0.743, P < 0.0001) and with its individual components. In conclusion, our data suggest that an impaired myocardial glucose metabolism may represent an early cardio-metabolic defect in individuals with the coexistence of type 2 diabetes and metabolic syndrome, regardless of whole-body insulin resistance.
Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic 18F-FDG-PET Study
Succurro, Elena;Vizza, Patrizia;Papa, Annalisa;Cicone, Francesco;Monea, Giuseppe;Tradigo, Giuseppe;Fiorentino, Teresa Vanessa;Perticone, Maria;Guzzi, Pietro Hiram;Sciacqua, Angela;Andreozzi, Francesco;Veltri, Pierangelo;Cascini, Giuseppe Lucio;Sesti, Giorgio
2022-01-01
Abstract
Metabolic syndrome is a condition characterized by a clustering of metabolic abnormalities associated with an increased risk of type 2 diabetes and cardiovascular disease. An impaired insulin-stimulated myocardial glucose metabolism has been shown to be a risk factor for the development of cardiovascular disease in patients with type 2 diabetes. Whether cardiac insulin resistance occurs in subjects with metabolic syndrome remains uncertain. To investigate this issue, we evaluated myocardial glucose metabolic rate using cardiac dynamic F-18-FDG-PET combined with euglycemic-hyperinsulinemic clamp in three groups: a group of normal glucose tolerant individuals without metabolic syndrome (n = 10), a group of individuals with type 2 diabetes and metabolic syndrome (n = 19), and a group of subjects with type 2 diabetes without metabolic syndrome (n = 6). After adjusting for age and gender, individuals with type 2 diabetes and metabolic syndrome exhibited a significant reduction in insulin-stimulated myocardial glucose metabolic rate (10.5 +/- 9.04 mu mol/min/100 g) as compared with both control subjects (32.9 +/- 9.7 mu mol/min/100 g; P < 0.0001) and subjects with type 2 diabetes without metabolic syndrome (25.15 +/- 4.92 mu mol/min/100 g; P = 0.01). Conversely, as compared with control subjects (13.01 +/- 8.53 mg/min x Kg FFM), both diabetic individuals with metabolic syndrome (3.06 +/- 1.7 mg/min x Kg FFM, P = 0.008) and those without metabolic syndrome (2.91 +/- 1.54 mg/min x Kg FFM, P = 0.01) exhibited a significant reduction in whole-body insulin-stimulated glucose disposal, while no difference was observed between the 2 groups of subjects with type 2 diabetes with or without metabolic syndrome. Univariate correlations showed that myocardial glucose metabolism was positively correlated with insulin-stimulated glucose disposal (r = 0.488, P = 0.003), and negatively correlated with the presence of metabolic syndrome (r = -0.743, P < 0.0001) and with its individual components. In conclusion, our data suggest that an impaired myocardial glucose metabolism may represent an early cardio-metabolic defect in individuals with the coexistence of type 2 diabetes and metabolic syndrome, regardless of whole-body insulin resistance.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.